Pharmocoeconomic aspects of losartan treatment to delay progression of renal disease inpatients with Type 2 diabetes

Maarten Postma, H. Kruidhof, Lolkje Theodora Wilhelmina de Jong-van den Berg, Dick de Zeeuw

Research output: Contribution to journalArticleAcademicpeer-review

Original languageDutch
Pages (from-to)1543 - 50
JournalPharmaco Therapy
Issue numberExpert Opinions
Publication statusPublished - 2003

Cite this